UBS Group’s Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock CYCCP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,378
| Closed | -$25.2K | – | 8972 |
|
|
2025
Q1 | $25.2K | Buy |
5,378
+5,294
| +6,302% | +$24.8K | ﹤0.01% | 6767 |
|
|
2024
Q4 | $612 | Buy |
+84
| New | +$612 | ﹤0.01% | 8161 |
|
|
2024
Q1 | – | Sell |
-17
| Closed | -$277 | – | 8185 |
|
|
2023
Q4 | $277 | Buy |
+17
| New | +$277 | ﹤0.01% | 7537 |
|
|
2023
Q3 | – | Sell |
-6
| Closed | -$66 | – | 8348 |
|
|
2023
Q2 | $66 | Sell |
6
-17
| -74% | -$187 | ﹤0.01% | 7483 |
|
|
2023
Q1 | $321 | Buy |
+23
| New | +$321 | ﹤0.01% | 7973 |
|
|
2022
Q4 | – | Sell |
-548
| Closed | -$4K | – | 9543 |
|
|
2022
Q3 | $4K | Buy |
548
+45
| +9% | +$328 | ﹤0.01% | 8240 |
|
|
2022
Q2 | $4K | Sell |
503
-126
| -20% | -$1K | ﹤0.01% | 8010 |
|
|
2022
Q1 | $4K | Sell |
629
-48
| -7% | -$305 | ﹤0.01% | 8224 |
|
|
2021
Q4 | $4K | Buy |
+677
| New | +$4K | ﹤0.01% | 8382 |
|
|
2020
Q2 | – | Sell |
-3,891
| Closed | -$23K | – | 7088 |
|
|
2020
Q1 | $23K | Sell |
3,891
-176
| -4% | -$1.04K | ﹤0.01% | 5493 |
|
|
2019
Q4 | $20K | Sell |
4,067
-361
| -8% | -$1.78K | ﹤0.01% | 5808 |
|
|
2019
Q3 | $20K | Buy |
4,428
+2,200
| +99% | +$9.94K | ﹤0.01% | 5766 |
|
|
2019
Q2 | $11K | Sell |
2,228
-187
| -8% | -$923 | ﹤0.01% | 6124 |
|
|
2019
Q1 | $11K | Buy |
2,415
+100
| +4% | +$455 | ﹤0.01% | 5902 |
|
|
2018
Q4 | $12K | Buy |
2,315
+151
| +7% | +$783 | ﹤0.01% | 6207 |
|
|
2018
Q3 | $11K | Hold |
2,164
| – | – | ﹤0.01% | 6189 |
|
|
2018
Q2 | $15K | Buy |
2,164
+1
| +0% | +$7 | ﹤0.01% | 5962 |
|
|
2018
Q1 | $13K | Buy |
2,163
+1,593
| +279% | +$9.57K | ﹤0.01% | 5825 |
|
|
2017
Q4 | $4K | Buy |
570
+300
| +111% | +$2.11K | ﹤0.01% | 6478 |
|
|
2017
Q3 | $2K | Buy |
+270
| New | +$2K | ﹤0.01% | 6537 |
|
|
2017
Q2 | – | Sell |
-609
| Closed | -$4K | – | 6713 |
|
|
2017
Q1 | $4K | Sell |
609
-1,356
| -69% | -$8.91K | ﹤0.01% | 6129 |
|
|
2016
Q4 | $12K | Buy |
1,965
+1,279
| +186% | +$7.81K | ﹤0.01% | 5850 |
|
|
2016
Q3 | $5K | Sell |
686
-768
| -53% | -$5.6K | ﹤0.01% | 6183 |
|
|
2016
Q2 | $9K | Buy |
1,454
+860
| +145% | +$5.32K | ﹤0.01% | 5939 |
|
|
2016
Q1 | $3K | Buy |
594
+432
| +267% | +$2.18K | ﹤0.01% | 6313 |
|
|
2015
Q4 | $1K | Sell |
162
-1
| -0.6% | -$6 | ﹤0.01% | 6695 |
|
|
2015
Q3 | $1K | Hold |
163
| – | – | ﹤0.01% | 6690 |
|
|
2015
Q2 | $1K | Sell |
163
-2
| -1% | -$12 | ﹤0.01% | 6644 |
|
|
2015
Q1 | $1K | Sell |
165
-7
| -4% | -$42 | ﹤0.01% | 6524 |
|
|
2014
Q4 | $1K | Buy |
+172
| New | +$1K | ﹤0.01% | 6683 |
|